candesartan has been researched along with cadmium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, MA; Ali, FEM; Gad-Elrab, WM; Hassanein, EHM; Kamel, EO; Mohammedsaleh, ZM | 1 |
1 other study(ies) available for candesartan and cadmium
| Article | Year |
|---|---|
Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals.
Topics: Angiotensin II; bcl-2-Associated X Protein; Cadmium; Hepatorenal Syndrome; Humans; NF-E2-Related Factor 2; NF-kappa B | 2023 |